NRX Pharmaceuticals (NRXP) EBIT (2017 - 2026)
NRX Pharmaceuticals' EBIT was -$6.51 million in Q2 2026, compared with -$3.73 million a year earlier.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) EBIT (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, NRX Pharmaceuticals' EBIT was -$19.9 million through Jun 30, 2026; for FY2025, it came in at -$16.22 million.
- In earlier years, EBIT was -$18.5 million in FY2024, -$27.84 million in FY2023, -$44.34 million in FY2022 and -$115.8 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBIT since Q2 2024.
- Per Business Quant data, NRXP's EBIT in the three quarters before Q2 2026 was -$4.74 million (Q1 2026), -$4.62 million (Q4 2025) and -$4.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 4.27 Bn |
| 10 | NRX Pharmaceuticals | 88.10 Mn | 39.69 Mn | 426,000.00 | -6.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.51 Mn |
| Mar 31, 2026 | -4.74 Mn |
| Dec 31, 2025 | -4.62 Mn |
| Sep 30, 2025 | -4.02 Mn |
| Jun 30, 2025 | -3.73 Mn |
| Mar 31, 2025 | -3.85 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -7.05 Mn |
| Mar 31, 2024 | -6.00 Mn |
| Dec 31, 2023 | -4.41 Mn |
| Sep 30, 2023 | -5.81 Mn |
| Jun 30, 2023 | -8.19 Mn |
| Mar 31, 2023 | -3.85 Mn |
| Dec 31, 2022 | -9.89 Mn |
| Sep 30, 2022 | -9.14 Mn |
| Jun 30, 2022 | -9.60 Mn |
| Mar 31, 2022 | -15.71 Mn |
| Dec 31, 2021 | -52.98 Mn |
| Sep 30, 2021 | -20.10 Mn |
API Access
NRX Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();